Will #AI enhance care of patients?
Yes!
How?
-Improved reliability
-Atherosclerosis guided Rx
-Risk prediction
-Requires validation ✅
Proud to share my #SCCT2021 talk (1/5)
AI & ML in #YesCCT: New Frontiers in Atherosclerosis
@mirvatalasnag @HeartOTXHeartMD @DrIanWeissman
#SCCT2021 (2/5)
AI & ML in #YesCCT: New Frontiers in Atherosclerosis
-The field of #YesCCT has evolved rapidly
-Current CV risk prediction models are inadequate – can AI help?
-Average imager may read > 1 billion pixels per day
#SCCT2021 (3/5)
#AI & ML in #YesCCT: Atherosclerosis
-Be mindful of caveats, ensure validity & avoid hype
-Opportunity to improve #CCT reproducibility (in conjunction w/ education!)
-#CLARIFY - algorithm validation
-#CLARIFY– high accuracy for %stenosis
@mirvatalasnag
#AI/ML in #YesCCT: Atherosclerosis #SCCT2021 (4/5)
-Comprehensive evaluation of atherosclerosis that is challenging, even for expert readers!
-Plaque allows us to understand the spectrum of atherosclerotic risk
-Low stenosis patient may have high plaque volume!
@mirvatalasnag
#AI & #ML in #YesCCT: Atherosclerosis #SCCT2021 (5/5)
-New future paradigm of AI guided prevention is emerging
-Opportunities to study disease progression
-Potential to better understand Rx non-response
-Ensure rigor-#PRIME
-The future is here!
@mirvatalasnag @HeartOTXHeartMD
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.